FRANKFURT (Reuters) -Swiss drugmaker Roche has abandoned global targets for a more diverse workforce to avoid penalties from recent U.S. executive orders, the latest in a slew of companies to do so. Among measures taken, Roche said its Chief Diversity Offices in the U.S. and at its Basel headquarters “will focus on inclusion and belonging, and responsibilities will be re-scoped accordingly”. According to a memo to global staff made available to Reuters, the changes were made to ensure that Roche “can continue to deliver medicines and diagnostic solutions to patients”.Read More
